(S)-imino(methyl)(phenyl)-lambda6-sulfanone, 98%, 100mg

Dimethyl-2,4-dihydroxyphenylsulfonium triflate, 99.9%, 5g

ethyl 5-(2,5-dimethoxyphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 1g

Monohidrato de ácido cítrico 99,5 %, FG 2.5 kilogramo

TAZEMETOSTAT, 98%, 1g

4-Cloroanilina, >=98%, para síntesis, 1 kg, envase de vidrio

Thieno[3,4-b]pyrazine, 95%, 250mg

n-Nonano, 99%, para síntesis, 250 ml, envase de vidrio

Imidazo[1,2-a]pyridine-3-carboxylic acid, 6-[5-[(phenylsulfonyl)amino]-3-pyridinyl]-, ethyl ester, 97%, 1g

Ethyl 5-bromo-1-methyl-1H-pyrazole-4-carboxylate, 95.0%, 1g

(2S)-2-(Fmoc-amino)dodecanoic acid, 95%, 250mg

p-(Octyloxyphenyl)phenyliodonium hexafluor antimonate, 250mg

(E)-ETHYL 2-(1-CARBAMOYL-2-((5-NITROFURAN-2-YL)METHYLENE)HYDRAZINYL)ACETATE, 90.0%, 1g